What Does Precocious Puberty Mean?

Sexual precocity, also known as precocious puberty, refers to the early onset of secondary sexual characteristics before age 8 in girls and before age 9 in boys. This condition involves the premature activation of the hypothalamic–pituitary–gonadal (HPG) axis, leading to elevated sex hormone levels and accelerated physical maturation. In girls, signs may include breast development, pubic hair growth, menarche, or rapid height velocity; in boys, manifestations can include testicular enlargement, facial or pubic hair, voice deepening, and increased muscle mass.

Clinically, precocious puberty is categorized into two main types: central (gonadotropin-dependent) and peripheral (gonadotropin-independent). Central precocious puberty results from premature reactivation of the HPG axis—often idiopathic but occasionally linked to structural brain abnormalities, infections, or tumors. Peripheral precocious puberty arises from excess sex hormone production independent of gonadotropin stimulation, such as in congenital adrenal hyperplasia, ovarian cysts, or exogenous hormone exposure.

Diagnosis requires a thorough evaluation, including detailed history, physical examination using Tanner staging, bone age assessment via hand–wrist radiography, serum hormone testing (e.g., luteinizing hormone, follicle-stimulating hormone, estradiol, testosterone), and, when indicated, gonadotropin-releasing hormone (GnRH) stimulation testing or neuroimaging. Early identification is critical—not only to address potential underlying pathology but also to mitigate psychosocial challenges and prevent compromised adult height due to premature epiphyseal fusion.

Management depends on etiology and progression. For progressive central precocious puberty, gonadotropin-releasing hormone analogues (GnRHa)—such as leuprolide or triptorelin—are first-line therapy to suppress HPG axis activity, delay further pubertal development, and preserve growth potential. Peripheral cases require targeted treatment of the underlying cause, such as glucocorticoid replacement in adrenal disorders or surgical intervention for hormone-secreting tumors.